High vulnerability of the heart and liver to 3‐hydroxypalmitic acid–induced disruption of mitochondrial functions in intact cell systems
- 20 June 2018
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 119 (9) , 7678-7686
Abstract
Patients affected by long‐chain 3‐hydroxyacyl‐CoA dehydrogenase (LCHAD) deficiency predominantly present severe liver and cardiac dysfunction, as well as neurological symptoms during metabolic crises, whose pathogenesis is still poorly known. In this study, we demonstrate for the first time that pathological concentrations of 3‐hydroxypalmitic acid (3HPA), the long‐chain hydroxyl fatty acid (LCHFA) that most accumulates in LCHAD deficiency, significantly decreased adenosine triphosphate‐linked and uncoupled mitochondrial respiration in intact cell systems consisting of heart fibers, cardiomyocytes, and hepatocytes, but less intense in diced forebrain. 3HPA also significantly reduced mitochondrial Ca2+ retention capacity and membrane potential in Ca2+‐loaded mitochondria more markedly in the heart and the liver, with mild or no effects in the brain, supporting a higher susceptibility of the heart and the liver to the toxic effects of this fatty acid. It is postulated that disruption of mitochondrial energy and Ca2+ homeostasis caused by the accumulation of LCHFA may contribute toward the severe cardiac and hepatic clinical manifestations observed in the affected patients.Keywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (425914/2016-0)
- Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul (2266-2551/14-2)
This publication has 48 references indexed in Scilit:
- Mitochondrial Ca 2+ uptake contributes to buffering cytoplasmic Ca 2+ peaks in cardiomyocytesProceedings of the National Academy of Sciences, 2012
- Mitochondrial DNA content and mass increase in progression from normal to hyperplastic to cancer endometriumBMC Research Notes, 2012
- IL-6 promotes nonthyroidal illness syndrome by blocking thyroxine activation while promoting thyroid hormone inactivation in human cellsJournal of Clinical Investigation, 2011
- Mitochondrial fatty acid oxidation disorders: clinical presentation of long‐chain fatty acid oxidation defects before and after newborn screeningJournal of Inherited Metabolic Disease, 2010
- Disturbance of mitochondrial energy homeostasis caused by the metabolites accumulating in LCHAD and MTP deficiencies in rat brainLife Sciences, 2010
- Treatment recommendations in long‐chain fatty acid oxidation defects: consensus from a workshopJournal of Inherited Metabolic Disease, 2009
- Methylmalonate inhibits succinate‐supported oxygen consumption by interfering with mitochondrial succinate uptakeJournal of Inherited Metabolic Disease, 2008
- Pathology of Long-Chain 3-Hydroxyacyl-Coa Dehydrogenase Deficiency Caused by the G1528C MutationPediatric Pathology & Laboratory Medicine, 1997
- Inhibitory effect of 3‐hydroxyacyl‐CoAs and other long‐chain fatty acidβ‐oxidation intermediates on mitochondrial oxidative phosphorylationJournal of Inherited Metabolic Disease, 1996
- 3-hydroxydicarboxylic aciduria—a fatty acid oxidation defect with severe prognosisThe Journal of Pediatrics, 1990